import { buildPageMetadata } from '../../../../src/lib/seo'
import Image from 'next/image'
import type { Metadata } from 'next'
import Link from 'next/link'
import AffiliateDisclosure from '../../../../components/AffiliateDisclosure'
import AuthorityBreadcrumbs from '@/components/navigation/AuthorityBreadcrumbs'
import { ArticleLayout, TableOfContents } from '@/components/articles'
import type { Heading } from '@/components/articles'
import References from '@/components/References'
import AuthorityJsonLd from '@/components/seo/AuthorityJsonLd'

export const metadata: Metadata = buildPageMetadata({
  title: 'Kratom 7-OH Withdrawal: Harm Reduction Guide',
  description: 'Comprehensive evidence-informed guide to 7-hydroxymitragynine (7-OH) withdrawal management, symptom timeline, harm reduction strategies, and medical support context.',
  path: '/guides/other/kratom-7oh-withdrawal-management/',
})

const HEADINGS: Heading[] = [
  { id: 'understanding', text: 'Understanding 7-OH and Withdrawal', level: 2 },
  { id: 'timeline', text: 'Withdrawal Timeline', level: 2 },
  { id: 'symptoms', text: 'Common Withdrawal Symptoms', level: 2 },
  { id: 'strategies', text: 'Harm Reduction Strategies', level: 2 },
  { id: 'relapse', text: 'Relapse Prevention', level: 2 },
  { id: 'emergency', text: 'When to Seek Emergency Care', level: 2 },
  { id: 'takeaways', text: 'Key Takeaways', level: 2 },
  { id: 'faq', text: 'Frequently Asked Questions', level: 2 },
]

const FAQS = [
  {
    question: 'Is there a standard at-home taper for kratom or concentrated 7-OH?',
    answer: 'No validated schedule works safely for every product or person. Concentrated 7-OH products can differ substantially from kratom leaf, and labels may not reflect actual exposure. A clinician or addiction-medicine professional should individualize any reduction plan.',
  },
  {
    question: 'Are concentrated 7-OH products the same as kratom leaf?',
    answer: 'No. FDA distinguishes concentrated or enhanced 7-OH products from traditional kratom leaf. Some products contain added or unusually high 7-OH and may create greater opioid-like risk.',
  },
  {
    question: 'Can supplements replace medical treatment during withdrawal?',
    answer: 'No supplement has reliable evidence as a treatment for kratom or 7-OH withdrawal. Avoid substituting another psychoactive or sedating product. Clinicians can assess dehydration, mental-health risk, co-use, and whether evidence-based addiction treatment is appropriate.',
  },
  {
    question: 'When does withdrawal require urgent help?',
    answer: 'Seek urgent or emergency care for trouble breathing, chest pain, seizure, severe confusion, fainting or severe dehydration, suicidal thoughts, or rapidly worsening symptoms. In the United States, call or text 988 for a mental-health crisis and 911 for an immediate emergency.',
  },
] as const

const KRATOM_7OH_WITHDRAWAL_MANAGEMENT_REFS = [
  { n: 1, text: 'Prozialeck WC, et al. (2012). Pharmacology of kratom: an emerging botanical agent. J Am Osteopath Assoc, 112(12): 792-799.', url: 'https://pubmed.ncbi.nlm.nih.gov/23212430/' },
  { n: 2, text: 'Swogger MT, et al. (2015). Kratom use and mental health: a systematic review. Drug Alcohol Depend, 183: 134-140.', url: 'https://pubmed.ncbi.nlm.nih.gov/29248691/' },
  { n: 3, text: 'Kruegel AC, Grundmann O. (2018). The medicinal chemistry and neuropharmacology of kratom. Neuropharmacology, 134(Pt A): 108-120.', url: 'https://pubmed.ncbi.nlm.nih.gov/28830758/' },
  { n: 4, text: 'Stanciu CN, et al. (2019). Kratom Withdrawal: A Systematic Review with Case Series. Journal of Psychoactive Drugs, 51(1): 12-18.', url: 'https://pubmed.ncbi.nlm.nih.gov/30614408/' },
  { n: 5, text: 'Weiss ST, Douglas HE. (2021). Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review. Journal of Addiction Medicine, 15(2): 167-172.', url: 'https://pubmed.ncbi.nlm.nih.gov/32858563/' },
  { n: 6, text: 'U.S. Food and Drug Administration. (2025). FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine.', url: 'https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-firms-marketing-products-containing-7-hydroxymitragynine' },
  { n: 7, text: 'U.S. Food and Drug Administration. 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat.', url: 'https://www.fda.gov/files/drugs/published/7-hydroxymitragynin_7-oh_an_assessment_of_the_scientific_data_and_toxicological_concerns_around_an_emerging_opioid_threat.pdf' },
]

export default function Page() {
  const toc = <TableOfContents headings={HEADINGS} />

  const breadcrumbs = [
    { label: 'Home', href: '/' },
    { label: 'Guides', href: '/guides' },
    { label: 'Kratom 7-OH Withdrawal Management' },
  ]

  return (
    <ArticleLayout toc={toc} zone="harm-reduction">
    <div className="space-y-8">
      <AuthorityJsonLd
        title="Kratom 7-OH Withdrawal: Harm Reduction Guide"
        description="Conservative, evidence-informed guidance on kratom and concentrated 7-OH withdrawal, medical support, emergency warning signs, and the limits of self-directed tapering."
        url="https://thehippiescientist.net/guides/other/kratom-7oh-withdrawal-management/"
        type="MedicalWebPage"
        breadcrumbs={[
          { name: 'Home', url: 'https://thehippiescientist.net/' },
          { name: 'Guides', url: 'https://thehippiescientist.net/guides/' },
          { name: 'Kratom 7-OH Withdrawal', url: 'https://thehippiescientist.net/guides/other/kratom-7oh-withdrawal-management/' },
        ]}
        faqItems={[...FAQS]}
        citationUrls={KRATOM_7OH_WITHDRAWAL_MANAGEMENT_REFS.map(reference => reference.url)}
      />
      <AuthorityBreadcrumbs items={breadcrumbs} />

      <section className="hero-shell rounded-[2rem] border border-brand-900/10 p-6 shadow-card sm:p-8">
        <p className="eyebrow-label">Harm Reduction Guide</p>
        <h1 className="mt-2 text-3xl font-semibold text-ink sm:text-4xl">Kratom 7-OH Withdrawal Management</h1>
        <p className="detail-reading mt-4 text-muted">A conservative guide to kratom and concentrated 7-hydroxymitragynine (7-OH) withdrawal, including symptom variability, the limits of self-directed tapering, and when to seek medical or addiction care.</p>

        <figure className="mt-6">
          <div className="overflow-hidden rounded-2xl border border-brand-900/10 shadow-sm bg-white">
            <Image
              src="/images/guides/kratom-7oh-withdrawal-management.jpg"
              alt="Green kratom leaf powder and a dried kratom leaf"
              width={1536}
              height={1024}
              priority
              className="w-full h-auto"
            />
          </div>
          <figcaption className="mt-3 text-center text-sm text-muted">
            Kratom and 7-OH — an educational harm-reduction overview.
          </figcaption>
        </figure>
      </section>

      <section className="rounded-2xl border border-rose-900/15 bg-rose-50/80 p-5 text-sm leading-6 text-rose-950">
        <p className="font-semibold">Jurisdiction and emergency-care notice</p>
        <p className="mt-2">
          7-hydroxymitragynine and kratom products are restricted, scheduled, or otherwise regulated in some U.S. states and countries.
          This page is for harm-reduction education only, does not endorse possession or use, and is not legal advice.
          Check your local law and seek licensed medical care for severe withdrawal, suicidal thoughts, chest pain, dehydration, seizures, or unsafe home conditions.
        </p>
      </section>

      <AffiliateDisclosure />

      <section className="prose-section space-y-6">
        <div className="card-premium p-6">
          <p className="text-sm font-semibold text-brand-700 uppercase tracking-wide">Important Disclaimer</p>
          <p className="mt-3 text-sm text-muted">This guide is educational only and does not constitute medical advice. Withdrawal symptoms can vary significantly by individual, dose history, duration of use, and underlying health status. Always consult a healthcare provider before changing kratom use, especially if you have medical conditions, take medications, or experience severe withdrawal symptoms. This guide is intended for harm reduction and evidence-informed decision-making, not as a replacement for professional medical care.</p>
        </div>

        <div id="understanding" className="scroll-mt-20">
          <h2 className="text-2xl font-semibold text-ink mt-6 mb-4">Understanding 7-OH and Withdrawal</h2>
          <p className="text-muted leading-relaxed">
            7-Hydroxymitragynine (7-OH) has opioid-receptor activity and occurs only in trace amounts in kratom leaf. Concentrated tablets, gummies, shots, and “enhanced” products can be materially different exposures; FDA has warned that added or enhanced 7-OH is not a lawful dietary-supplement ingredient and may be dangerous [6,7]. Repeated use can lead to dependence and withdrawal. For pharmacology and regulatory context, read the <Link href="/compounds/7-hydroxymitragynine/" className="font-semibold text-brand-800 hover:underline">full 7-OH evidence monograph</Link>.
          </p>
        </div>

        <div id="timeline" className="scroll-mt-20">
          <h3 className="text-xl font-semibold text-ink mt-6 mb-3">Why no universal timeline is shown</h3>
          <p className="text-sm text-muted mb-4">Published evidence is mostly case reports, small case series, and self-reported kratom exposure. It does not validate one hour-by-hour schedule for kratom leaf, extracts, and concentrated 7-OH products [4].</p>
          <ul className="list-disc space-y-2 pl-5 text-sm text-muted">
            <li>Onset and duration can change with the product, actual alkaloid exposure, frequency of use, and time since the last dose.</li>
            <li>Alcohol, opioids, benzodiazepines, stimulants, or other substances can change both symptoms and medical risk.</li>
            <li>Persistent insomnia, low mood, cravings, or anxiety deserve follow-up rather than an assumption that every symptom is a normal phase.</li>
            <li>A clinician can use symptoms, vital signs, hydration, mental-health status, and co-use—not a generic internet timeline—to guide care.</li>
          </ul>
        </div>

        <div id="symptoms" className="scroll-mt-20">
          <h3 className="text-xl font-semibold text-ink mt-6 mb-3">Common Withdrawal Symptoms</h3>
          <p className="text-sm text-muted mb-4">Physical and psychological effects typically observed:</p>
          <div className="grid gap-3 grid-cols-1 md:grid-cols-2">
            <div className="space-y-2 text-sm">
              <p className="font-semibold text-ink">Physical Symptoms</p>
              <ul className="list-disc pl-5 space-y-1 text-muted">
                <li>Muscle and body aches</li>
                <li>Chills and temperature dysregulation</li>
                <li>Sweating and night sweats</li>
                <li>Gastrointestinal distress</li>
                <li>Insomnia and sleep disruption</li>
                <li>Fatigue and low energy</li>
                <li>Dilated pupils</li>
                <li>Headaches</li>
                <li>Increased heart rate</li>
              </ul>
            </div>
            <div className="space-y-2 text-sm">
              <p className="font-semibold text-ink">Psychological Symptoms</p>
              <ul className="list-disc pl-5 space-y-1 text-muted">
                <li>Anxiety and panic</li>
                <li>Irritability and mood swings</li>
                <li>Dysphoria (emotional flatness, low mood)</li>
                <li>Difficulty concentrating</li>
                <li>Anhedonia (loss of pleasure)</li>
                <li>Cravings for kratom</li>
                <li>Restlessness and agitation</li>
                <li>Appetite loss</li>
                <li>Intrusive thoughts or rumination</li>
              </ul>
            </div>
          </div>
        </div>

        <div id="strategies" className="scroll-mt-20">
          <h2 className="text-2xl font-semibold text-ink mt-8 mb-4">Harm Reduction Strategies</h2>

          <h3 className="text-xl font-semibold text-ink mt-6 mb-3">Do not copy a percentage taper from the internet</h3>
          <p className="text-muted mb-4">There is no validated self-directed taper schedule for concentrated 7-OH, and product labels may not provide a reliable measure of opioid-like exposure. The published treatment literature is limited and includes clinician-managed case reports rather than a universal protocol [4,5].</p>

          <div className="space-y-4">
            <div className="border-l-4 border-brand-200 pl-4">
              <p className="font-semibold text-ink">Document the actual product</p>
              <p className="text-sm text-muted mt-2">Bring the package or clear label photos to a clinician. Record the form, labeled alkaloid amount, servings used, timing, co-used substances, and any recent product changes.</p>
            </div>

            <div className="border-l-4 border-brand-200 pl-4">
              <p className="font-semibold text-ink">Ask for an individualized assessment</p>
              <p className="text-sm text-muted mt-2">Medical history, pregnancy, mental-health symptoms, prior opioid use, co-use, and the ability to stay hydrated or safe at home can materially change the appropriate level of care.</p>
            </div>

            <div className="border-l-4 border-brand-200 pl-4">
              <p className="font-semibold text-ink">Discuss evidence-based addiction care</p>
              <p className="text-sm text-muted mt-2">Case reports describe clinician-managed buprenorphine/naloxone for some people with kratom-associated opioid use disorder, but this is prescription treatment—not a do-it-yourself substitution—and the evidence base remains limited [5].</p>
            </div>

            <div className="border-l-4 border-brand-200 pl-4">
              <p className="font-semibold text-ink">Plan support and escalation</p>
              <p className="text-sm text-muted mt-2">Arrange check-ins, transportation, hydration, and a clear threshold for urgent care. Do not attempt withdrawal alone if there is severe dependence, unstable mental health, pregnancy, serious illness, or heavy use of other depressants.</p>
            </div>
          </div>

          <p className="text-sm text-muted mt-6">In the United States, SAMHSA’s National Helpline (1-800-662-HELP) can help locate treatment. Call or text 988 for a mental-health crisis and 911 for an immediate emergency.</p>
        </div>

        <div>
          <h3 className="text-xl font-semibold text-ink mt-6 mb-3">Symptom Management</h3>

          <div className="space-y-4">
            <div>
              <p className="font-semibold text-ink">Sleep Support</p>
              <p className="text-sm text-muted mt-2">Insomnia is a primary complaint. Non-pharmacological approaches: establish consistent sleep schedule, avoid caffeine, use cool bedroom environment, limit screen time before bed, practice relaxation techniques. If severe, medical consultation for short-term sleep support may be appropriate.</p>
            </div>

            <div>
              <p className="font-semibold text-ink">Pain and Muscle Aches</p>
              <p className="text-sm text-muted mt-2">Heat application (warm bath, heating pad), light stretching, non-strenuous movement, and over-the-counter pain management (per provider guidance) may help. Avoid strenuous exercise during peak withdrawal, but gentle movement (walking, yoga) can reduce overall discomfort and support mood.</p>
            </div>

            <div>
              <p className="font-semibold text-ink">Gastrointestinal Distress</p>
              <p className="text-sm text-muted mt-2">Stay hydrated, eat small frequent meals, avoid heavy or spicy foods, use ginger or peppermint tea if tolerated. If severe diarrhea or constipation develops, medical consultation is warranted.</p>
            </div>

            <div>
              <p className="font-semibold text-ink">Anxiety and Mood Support</p>
              <p className="text-sm text-muted mt-2">Grounding techniques (5-4-3-2-1 sensory method), breathing exercises (4-7-8 breathing), meditation apps, journaling, and social connection all support psychological withdrawal. Professional mental health support is valuable, especially for individuals with depression or anxiety history.</p>
            </div>

            <div>
              <p className="font-semibold text-ink">Hydration and Nutrition</p>
              <p className="text-sm text-muted mt-2">Withdrawal accelerates fluid loss and electrolyte imbalance. Drink adequate water, consider electrolyte beverages (coconut water, sports drinks), and maintain nutrition despite appetite loss. Nutritional support may ease fatigue and support mood regulation.</p>
            </div>
          </div>
        </div>

        <div>
          <h3 className="text-xl font-semibold text-ink mt-6 mb-3">Medical and Professional Support</h3>
          <p className="text-muted mb-4">Healthcare providers can offer evidence-based support during kratom withdrawal:</p>

          <ul className="space-y-3 text-muted pl-5">
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Assessment:</span>
              <span>Evaluation of overall health, medication interactions, mental health history, and severity of dependence to tailor a withdrawal plan</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Monitoring:</span>
              <span>Regular check-ins to monitor symptoms, adjust plans, and identify complications</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Symptomatic Treatment:</span>
              <span>Short-term use of approved medications to manage specific symptoms (e.g., sleep aids, anti-anxiety agents) under medical supervision</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Mental Health Support:</span>
              <span>Therapy or counseling to address psychological withdrawal, underlying causes of kratom use, and relapse prevention</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Substance Use Specialist Referral:</span>
              <span>Connection to addiction medicine specialists or substance use disorder treatment programs if appropriate</span>
            </li>
          </ul>
        </div>

        <div id="relapse" className="scroll-mt-20">
          <h2 className="text-2xl font-semibold text-ink mt-8 mb-4">Relapse Prevention</h2>
          <p className="text-muted mb-4">After completing withdrawal, preventing return to kratom use is critical:</p>

          <ul className="space-y-3 text-muted pl-5">
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Identify Triggers:</span>
              <span>Recognize situations, emotions, or people that prompted kratom use and plan alternative responses</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Build Support Network:</span>
              <span>Maintain connection to healthcare providers, therapists, support groups, or trusted individuals who support your abstinence</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Lifestyle Modifications:</span>
              <span>Establish healthy routines for sleep, exercise, nutrition, and stress management to reduce protracted withdrawal and cravings</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Address Underlying Conditions:</span>
              <span>If kratom use masked pain, anxiety, depression, or other conditions, seek appropriate medical or therapeutic treatment for those conditions</span>
            </li>
            <li className="flex gap-3">
              <span className="font-semibold text-ink min-w-fit">Avoid Triggers:</span>
              <span>When possible, avoid people, places, or situations associated with kratom use during early recovery</span>
            </li>
          </ul>
        </div>

        <div id="emergency" className="scroll-mt-20">
          <h2 className="text-2xl font-semibold text-ink mt-8 mb-4">When to Seek Emergency Care</h2>
          <p className="text-muted mb-4">Contact emergency services or go to an emergency department if you experience:</p>

          <ul className="space-y-2 text-muted pl-5 text-sm">
            <li>Chest pain or difficulty breathing</li>
            <li>Severe confusion, hallucinations, or altered consciousness</li>
            <li>Suicidal thoughts or severe self-harm urges</li>
            <li>Seizures</li>
            <li>Severe allergic reaction (rash, anaphylaxis)</li>
            <li>Severe dehydration with dizziness, fainting, or rapid heart rate</li>
            <li>Signs of infection (high fever, severe infection)</li>
            <li>Severe gastrointestinal bleeding</li>
          </ul>

          <p className="text-muted mt-4 text-sm">These complications are rare but require immediate medical attention. Do not delay seeking emergency care due to stigma or fear of legal consequences—emergency providers are present to help, not judge.</p>
        </div>

        <div id="takeaways" className="scroll-mt-20">
          <h2 className="text-2xl font-semibold text-ink mt-8 mb-4">Key Takeaways</h2>
          <div className="space-y-3 text-muted pl-5">
            <p>• 7-OH withdrawal is a real physical and psychological process requiring patience and support, not willpower alone.</p>
            <p>• Concentrated 7-OH products are not equivalent to traditional kratom leaf and may carry greater opioid-like risk [6,7].</p>
            <p>• No validated internet taper or universal withdrawal timeline applies to every product and person.</p>
            <p>• Medical and mental-health support can identify complications and evidence-based treatment options.</p>
            <p>• Addressing underlying conditions (pain, anxiety, stress) reduces relapse risk.</p>
            <p>• Severe physical symptoms, suicidal thoughts, or an unsafe home situation require urgent help.</p>
          </div>
        </div>

        <div id="faq" className="scroll-mt-20">
          <h2 className="text-2xl font-semibold text-ink mt-8 mb-4">Frequently Asked Questions</h2>
          <div className="space-y-4">
            {FAQS.map(item => (
              <article key={item.question} className="rounded-2xl border border-brand-900/10 bg-[var(--surface-card)] p-5">
                <h3 className="font-semibold text-ink">{item.question}</h3>
                <p className="mt-2 text-sm leading-7 text-muted">{item.answer}</p>
              </article>
            ))}
          </div>
        </div>

        <div>
          <h2 className="text-2xl font-semibold text-ink mt-8 mb-4">References and Further Reading</h2>
          <p className="text-muted mb-4 text-sm">This guide synthesizes evidence from:</p>
          <ul className="space-y-2 text-muted pl-5 text-sm">
            <li>Clinical literature on opioid withdrawal management principles</li>
            <li>Pharmacological research on kratom alkaloids and mu-opioid receptor binding</li>
            <li>Harm reduction frameworks from addiction medicine and public health</li>
            <li>Patient-reported withdrawal experiences and coping strategies</li>
            <li>Medical guidelines on substance use disorder treatment and relapse prevention</li>
          </ul>
          <p className="text-muted mt-4 text-sm">Consult your healthcare provider for personalized information based on your specific health context and medication use.</p>
        </div>
      </section>

      <section className="card-premium p-6 mt-8">
        <p className="text-sm font-semibold text-brand-700 uppercase tracking-wide">Next Steps</p>
        <div className="mt-4 space-y-2 text-sm text-muted">
          <p>Speak with a healthcare provider about your withdrawal plan and access to medical support.</p>
          <p>Consider connecting with mental health services or support groups for additional support during the withdrawal process.</p>
          <p>Prepare your environment: stock non-addictive comfort items, arrange social support, and plan activities for distraction and mood support.</p>
        </div>
      </section>

      <div className="mt-8 flex gap-4 flex-wrap">
        <Link href="/guides/" className="text-sm font-medium text-emerald-700 hover:underline">Back to guides →</Link>
        <Link href="/compounds/7-hydroxymitragynine/" className="text-sm font-medium text-emerald-700 hover:underline">Read the 7-OH monograph →</Link>
        <Link href="/compounds/mitragynine/" className="text-sm font-medium text-emerald-700 hover:underline">Read the mitragynine monograph →</Link>
        <Link href="/guides/compare/" className="text-sm font-medium text-emerald-700 hover:underline">Browse supplement comparisons →</Link>
        <Link href="/compounds/kratom/" className="text-sm font-medium text-emerald-700 hover:underline">View kratom profile →</Link>
        <Link href="/compounds/7-hydroxymitragynine/" className="text-sm font-medium text-emerald-700 hover:underline">View 7-OH compound profile →</Link>
      </div>
    </div>
    <References refs={KRATOM_7OH_WITHDRAWAL_MANAGEMENT_REFS} />
    </ArticleLayout>
  )
}
